Pennsylvania has become the center of the outbreak as cases exceed 775 alongside conflicting mortality reports.
|Articles|July 30, 2013
VIDEO: Surviving as an independent
Tom Ohliger, RPh, an independent pharmacist from Fairview Park, Ohio, discusses the many challenges facing independent pharmacies.
Advertisement
Tom Ohliger, RPh, an independent pharmacist from Fairview Park, Ohio, discusses the many challenges facing independent pharmacies.
Advertisement
Related to this article
The LATA trial found long-acting cabotegravir–rilpivirine is better than daily oral therapy at keeping adolescents virologically suppressed.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Mark Garofoli, PharmD, BCGP, CPE, CTTS, explains how to guide patients past crowded combination products, uncertain decongestants, and hidden risks in OTC aisles.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Cohort studies found no clear cardiovascular benefit from PPV23 vaccination, leaving its role in cardiovascular prevention unresolved.
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
2
Q&A: Pharmacist Duties Highlight Need for Provider Status Legislation
3
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
4
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
5